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Purpose/Objective: We have investigated the impact of an 
implanted metal prosthesis on dose distributions in VMAT by 
using a QA water phantom including a metal cylinder. 
Materials and Methods: In order to evaluate the influence of 
the implanted metal prosthesis, we placed a 30 mm thick 
brass cylinder in the QA water phantom. Two plans were 
created: 1) VMAT with split arc segments thereby avoiding 
direct beam deliveries to the prosthesis and femur 
(hereinafter referred to as avoidance VMAT ), and 2) a single 
arc VMAT. We measured the isocenter dose by a Farmer-type 
ion detector and an axial dose distribution using radiochromic 
films with/without the brass cylinder. 
Results: The isocenter dose difference with or without the 
metal cylinder for each of the avoidance VMAT was negligibly 
small. However, a significant dose difference was observed 
for a normal single arc VMAT. Meanwhile, the difference of 
the dose distributions with or without the metal for the 
avoidance VMAT was insignificant. It was further observed 
that the avoidance VMAT led to insignificant dose differences 
in high dose areas such as prostate target, whereas the area 
close to the metal showed large dose differences possibly due 




Conclusions: We observed a significant impact of a metal 
object on dose distributions in VMAT when a single full arc 
beam was delivered. However VMAT beams with the 
avoidance angles did not suffer from the metal effect . This 
result encourages us to use a water phantom without a metal 
object for QA of a prostate cancer patient with a hip 
prosthesis. 
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Purpose/Objective: The purpose of this paper is to present 
the differences in the doses received by critical organs 
(bladder, rectum) during radiotherapy of prostate cancer 
limited to the organ, depending on the size of irradiation 
technology and CTV-PTV margin conditioned by an image 
verification method. 
Materials and Methods: The study was conducted on a group 
of 20 patients who were treated with radiotherapy between 
2012 and 2013. For each patient 20 alternative treatment 
plans were prepared. Plans differ from each other by method 
of irradiation and the size of the CTV-PTV margin. These 
were respectively: (i) the irradiation method - 3DCRT (3 
beams, 20 MV); IMRT (5 beams, 20 MV); IMRT (7 beams, 6 
MV); VMAT (2 arcs, 6 MV) and (ii) margins (M) expressed in 
[mm] and calculated for directions LR / CC / AP - M1 (2/3/4); 
M2 (3/4/5); M3 (6/5/6); M4 (7/6/6); M5 (8/7/7). The 
proposed margins are determined by the image verification 
method (Piotrowski et. Al., Technol Cancer Res Treat, 2014) 
and correspond respectively: M1 - daily CBCT verification; M2 
- CBCT verification during the first five fractions and 
verification of 2D-kV for the remaining fractions; M3 - CBCT 
verification during the first five fractions; M4 - 2D-kV 
verification during the first five fractions; M5 - no image 
verification, positioning based on the marks on the skin of 
the patient. Analysis on the average dose in the bladder and 
rectum, depending on the size of irradiation technology and 
CTV-PTV margin was conducted For statistical analysis, 
Friedman ANOVA test was used. Doses are presented in 
percentage and normalized to total dose (74Gy = 100%). The 
analysis was performed at the level of statistical significance 
equal to 0.05. 
Results: For both bladder and rectum average doses obtained 
for 3DCRT were significantly different from the dose for 
dynamic techniques (IMRT, VMAT) (p<0.01). The average 
difference between the bladder doses for 3DCRT and the 
dynamic techniques was 15%, for rectum difference was 7%. 
No statistically significant differences between the average 
doses for dynamic techniques (p>0.2) were found. Analysis of 
the average doses with respect to used margin showed that 
there were no statistically significant differences between 
the doses obtained for the margins M1 and M2 (p>0.4 for 
bladder and p>0.09 for rectum). Similar observations were 
obtained for doses on M3, M4 and M5 (p> 0.3 for bladder and 
rectum). However, the differences between doses for M1, M2 
and M3, M4 , M5 are statistically significant (p<0.01 for the 
bladder and p<0.03 for the rectum), averaging 10% of the 
bladder and 5% for rectum. 




Conclusions: The choice of the appropriate method of 
irradiation (3DCRT vs dynamic techniques) and using the 
appropriate margin determining the image verification 
method (daily verification vs verification for the first 
fractions) significantly affects the average doses in the 
bladder and rectum. 
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Purpose/Objective: Radiation-induced dysphagia is an 
undesirable toxicity in head and neck cancer (HNC) 
treatment. Radiotherapy (RT) delivered with HT might 
mitigate this toxicity. This is a retrospective review of HT 
treatment plans relating planning target volumes (PTVs) and 
organs-at-risk (OAR) dosimetry to severe toxicities.  
Materials and Methods: Seventy two HNC patients treated 
with curative HT were included, 55% of whom had stage IV 
disease and 47% localised in the oral cavity and oropharynx. 
Dose for definitive RT was 70 Gy and for post-operative RT 
60-66 Gy. 47% of patients received a simultaneously 
integrated boost. Severe G3-4 early and chronic toxicities 
(CTCAE version 3.0 and RTOG/EORTC scoring system) were 
scored and correlated with common risk factors. Dose 
distributions to PTVs and OARs were correlated to severe 
toxicities and treatment effectiveness, using COX regression 
and contingency analysis. Overall treatment time of radiation 
therapy (TTT) was reported, with 10 patients having been 
replanned during RT due to anatomical changes.  
Results: Age resulted in more acute severe toxicity. Older 
patients (>64y) had more pain and xerostomia (p=<0.0001) 
and younger patients had more dysphagia and dermitis 
(p=<0.0001) in a multivariate analysis. Median pathologic PTV 
volume was 131 cc (109-153 cc) and elective PTV 345cc (288-
402cc). We achieved excellent pathologic PTV coverage with 
the isodoses 95%, 98% and 2% covering 98%, 97% and 103% of 
volume, respectively. Isodoses 95%, 98% and 2% of elective 
PTV covered 100%, 98% and 127% of volume.  Severe early 
toxicities were 31% mucositis, 11% pain, 7% xerostomia, 52% 
dysphagia and 45% dermitis; 21% of patients developed severe 
chronic dysphagia. Larger p. PTVs (>131 cc) resulted in 
significant higher early dysphagia rates (64.8% vs. 35.14% 
(p=0.02)) and late dysphagia rates (47.9% vs. 52% (p=0.059)). 
Wider PTVs showed a trend of correlation to decreased 
overall survival rates (OS at 3y, 36% vs.74% (p=0.23)). 
Concerning TTT, only 24% of patients had a standard 
treatment duration (<47 days), 40% had an intermediate TTT 
prolongation deviation (47 to 54 days) and 8% an important 
TTT prolongation (>54 days) in TTT, with 29% of patients 
start treatment on Thursday or Friday. TTT was not related 
with acute or late severe toxicities, neither with OS. Patients 
replanned during treatment (10 p) experienced more acute 
toxicity (pain and xerostomia p<0.01), but not an improved in 
locorregional control or OS. Replanning induced significant 
longer TTT (p=0.0001).  
Conclusions: The use of HT improves the coverage of PTV 
volumes preserving salivary glands, even in great volumes. 
Higher doses to ipsilateral parotid (28Gy) and submaxilar 
gland (58Gy) seem to be related to severe toxicity. 
Replanification is related to more toxicity without 
improvement in disease control. Different toxicities by ages 
can be related with other factors like HPV presence (younger 
patients) and basal atrophic salivary glands (older patients). 
   
PO-1103   
Geometric and actual dose delivery accuracy in supine and 
prone position of breast tomotherapy  
G. Chiu1, W.W.K. Fung1, V.W.C. Wu2 
1Hong Kong Sanatorium & Hospital, Radiotherapy 
Department, Happy Valley, Hong Kong (SAR) China  
2Hong Kong Polytechnic University, Department of Health 
Technology and Informatics, Hunghom, Hong Kong (SAR) 
China  
 
Purpose/Objective: This study aims to evaluate the 
geometric and actual dose delivery accuracy in supine and 
prone positions of breast tomotherapy. 
Materials and Methods: Forty early breast cancer patients 
were recruited for tomotherapy after breast conservation 
surgery. The breast cup size was ≥ C and TNM staging was T0-
T3, N0-N1, M0. All patients received 25 fractions of 
treatment with 2 Gy/fr to total 50 Gy. Thirty were treated in 
supine position on customized vaclok during planning and 
treatment and ten were treated in prone position 
immobilized on prone breast board with customized vaclok. 
Daily MVCT was performed for treatment verification. For 
lateral, longitudinal and vertical dimensions, the offset 
distances in terms of mm before couch adjustment were 
recorded; while for the roll dimension, the degree of angle 
rotated were recorded. The difference in coordinates before 
and after matching in these four dimensional directions were 
recorded in each fraction for each patient. Systematic (SE) 
and random (RE) errors were calculated from the 
